Atai Life Sciences schizophrenia drug fails to meet main goal in mid-stage trial - TradingView

Reuters | July 25, 2025, 4:14 p.m. | Original
Atai Life Sciences schizophrenia drug fails to meet main goal in mid-stage trial TradingView
US judge reaffirms nationwide injunction blocking Trump executive order on birthright citizenship - TradingView Tesla plans to expand chartered transport service, California regulator says - TradingView